Writing
Tagged “ai”
4 pieces tagged “ai”, across articles and the blog.
-
Somewhere in industry, a chatbot just got blamed for a warning letter
FDA cited a firm that relied on AI for GMP documentation and then said it did not know process validation was required, because the AI never mentioned it.
-
AI is coming to the GMP quality system. Understanding has to come first.
FDA has a planned guidance on AI and machine learning in pharmaceutical manufacturing. Having evaluated process analytical technology from the inside, I think the hard part is not the model. It is the signature underneath it.
-
The regulatory door just opened for new approach methodologies
FDA’s draft guidance on non-animal methods runs on two principles: context of use and weight of evidence. Together they tell you exactly where a predictive model is allowed to sit.
-
A thinking tool, not a decision tool
Virtual cell models trained on causal perturbation data are a real scientific step up. Looked at from a regulatory perspective, they still sit upstream of anything FDA would accept as evidence.